Evidence map›Paper›PMID 30934597›Full record

ArticleNanomaterials (Basel, Switzerland)2019

Albumin Submicron Particles with Entrapped Riboflavin-Fabrication and Characterization.

Nittiya Suwannasom, Kathrin Smuda, Chiraphat Kloypan, Waraporn Kaewprayoon, Nuttakorn Baisaeng, Ausanai Prapan, Saranya Chaiwaree, Radostina Georgieva, Hans Bäumler

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Riboflavin: The Health Benefits of a Forgotten Natural Vitamin.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Nittiya SuwannasomInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Nittiya.Suwannasom@charite.de.ORCID 0000-0002-7069-5990
Kathrin SmudaInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Kathrin.smuda@charite.de.
Chiraphat KloypanInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. chiraphat.kloypan@charite.de.
Waraporn KaewprayoonInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Waraporn.Kaewprayoon@charite.de.
Nuttakorn BaisaengSchool of Pharmaceutical Sciences, University of Phayao, Phayao 56000, Thailand. patchateeya@yahoo.com.ORCID 0000-0002-0305-5854
Ausanai PrapanInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Ausanai.Prapan@charite.de.
Saranya ChaiwareeInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. Saranya.Chaiwaree@charite.de.ORCID 0000-0002-7209-7687
Radostina GeorgievaInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. radostina.georgieva@charite.de.ORCID 0000-0003-1546-5540
Hans BäumlerInstitute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. hans.baeumler@charite.de.ORCID 0000-0002-2573-2289
University of Phayao · THCharité - Universitätsmedizin Berlin · DEPayap University · THNaresuan University · THTrakia University · BG

Funding

European Research Council PIRSES-GA-2013-612673
6 · The paper itself

Abstract

Although riboflavin (RF) belongs to the water-soluble vitamins of group B, its solubility is low. Therefore, the application of micro-formulations may help to overcome this limiting factor for the delivery of RF. In this study we immobilized RF in newly developed albumin submicron particles prepared using the Co-precipitation Crosslinking Dissolution technique (CCD-technique) of manganese chloride and sodium carbonate in the presence of human serum albumin (HSA) and RF. The resulting RF containing HSA particles (RF-HSA-MPs) showed a narrow size distribution in the range of 0.9 to 1 μm, uniform peanut-like morphology, and a zeta-potential of -15 mV. In vitro release studies represented biphasic release profiles of RF in a phosphate buffered saline (PBS) pH 7.4 and a cell culture medium (RPMI) 1640 medium over a prolonged period. Hemolysis, platelet activation, and phagocytosis assays revealed a good hemocompatibility of RF-HSA-MPs.

Indexed as

biopolymerCCD-techniqueimmobilizationriboflavin

Identifiers

PMID30934597
PMCPMC6474188
OpenAlexW2924102382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.